According to the latest report published by Credence Research, Inc. “Organ on Chip Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global organ on chip market is expected to witness significant growth.
Direct recognition and investigation of biomolecules and cells in physiological microenvironment is essential for quick assessment of pharmacy and biology. The past several years have seen surprising improvements in the development of in vitro organs and tissues model with various purposes based on microfluidic devices known as organ on chip.
Browse Here for Full Report at https://goo.gl/hhvuGP
Organ on chip technology aims at creating imitation active organs that mimic the complex and biological reactions of actual organs, keeping in mind the goal to examine drugs’ action by exactly manipulating the cells and their microenvironments. To accomplish this, the artificial organs ought to be micro fabricated with an extracellular matrix (ECM) and different sorts of cells, and recapitulate morphogenesis, cell differentiation, and functions corresponding the local organ.
Based on the product types, the global organ on chip market is segmented into lungs on chip, heart on chip, liver on chip, kidney on chip, and others; additionally the end users studied in this report are categorized into research institutes, and pharmaceutical manufacturers. Advancement in technology of organ on chip is capable of accelerating the speed of drug testing, producing more reliable data, and dropping the financial and ethical drawbacks of preclinical research will boost the market of organ on chip.
Geographically, the overall organ on chip market is projected for Middle East and Africa, Europe, Latin America, Asia Pacific, and North America. As for revenue share, North America leads the global market and is expected that the situation will remain consistent amid the forecast period. Though the control of North America on the global market will be clearly challenged by Asia Pacific. The need of organ on chip has become prominent in Asia Pacific because of growth in the healthcare infrastructure, healthcare expenditure, and flexible income. There are massive chances for market diffusion in nations like India, Mexico, and China to the market occupants already having a grip in developed countries.
Get Free Sample Request: https://goo.gl/W7AncF
- Lungs on Chip
- Heart on Chip
- Liver in Chip
- Kidney on Chip
By End User
- Research Institutes
- Pharmaceutical Manufacturers
- Asia Pacific (Japan, China, and Rest of Asia Pacific)
- North America (Canada & United States)
- Middle East and Africa (GCC and Rest of Middle East and Africa)
- Europe (Germany, U.K., and Rest of Europe)
- Latin America (Mexico, Brazil, and Rest of Latin America)